First Horizon Advisors, Inc. - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.

Quarter-by-quarter ownership
First Horizon Advisors, Inc. ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$4,668
-11.7%
1720.0%0.00%
Q2 2023$5,287
-14.7%
1720.0%0.00%
Q1 2023$6,197
-8.8%
1720.0%0.00%
Q4 2022$6,797
-2.9%
1720.0%0.00%
Q3 2022$7,0000.0%1720.0%0.00%
Q2 2022$7,000
+40.0%
172
+41.0%
0.00%
Q1 2022$5,0001220.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2022
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$244,378,00079.54%
Vantage Consulting Group Inc 7,862,542$284,152,00060.85%
Memorial Sloan Kettering Cancer Center 2,680,644$96,878,00060.36%
Indie Asset Partners, LLC 701,323$25,346,00020.53%
HARVARD MANAGEMENT CO INC 7,142,856$258,143,00015.13%
Bleichroeder LP 1,115,980$40,332,0006.55%
Overbrook Management Corp 785,132$28,375,0006.16%
Geo Capital Gestora de Recursos Ltd 194,305$7,022,0003.21%
Brown University 621,759$22,470,0003.05%
Graypoint LLC 610,584$22,067,0002.71%
View complete list of ROYALTY PHARMA PLC shareholders